tak 779 has been researched along with HIV in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arenzana-Seisdedos, F | 1 |
| Clay, WC; Condreay, JP; Ferris, RG; Jenkinson, S; Kerner, SA; Lawrence, WK; McCoy, DC; Smith, CD | 1 |
| Fujioka, A; Harada, S; Maeda, Y; Monde, K; Yusa, K | 1 |
1 review(s) available for tak 779 and HIV
| Article | Year |
|---|---|
[Viral entry as therapeutic target. Current situation of entry inhibitors].
Topics: Adult; Amides; Benzoates; CCR5 Receptor Antagonists; CD4 Antigens; Chemokines, CC; Chemokines, CXC; Clinical Trials as Topic; Cyclohexanes; Diketopiperazines; Drug Design; env Gene Products, Human Immunodeficiency Virus; HIV; HIV Fusion Inhibitors; HIV Infections; Humans; Maraviroc; Membrane Fusion; Models, Molecular; Piperazines; Pyrimidines; Quaternary Ammonium Compounds; Receptors, CCR5; Receptors, CXCR4; Spiro Compounds; Structure-Activity Relationship; Triazoles; Virus Attachment; Virus Internalization | 2008 |
2 other study(ies) available for tak 779 and HIV
| Article | Year |
|---|---|
Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology.
Topics: Amides; Baculoviridae; Butyric Acid; CCR5 Receptor Antagonists; CD4 Antigens; Cell Fusion; Cell Line; Cell Line, Tumor; Cyclic N-Oxides; Dimethyl Sulfoxide; Gene Products, env; Gene Products, rev; Gene Products, tat; HIV; HIV Envelope Protein gp120; HIV Long Terminal Repeat; Humans; Oximes; Piperidines; Plasmids; Pyridines; Quaternary Ammonium Compounds; Receptors, CCR5; rev Gene Products, Human Immunodeficiency Virus; tat Gene Products, Human Immunodeficiency Virus; Transduction, Genetic; Transfection | 2003 |
Isolation of TAK-779-resistant HIV-1 from an R5 HIV-1 GP120 V3 loop library.
Topics: Amides; Amino Acid Sequence; Base Sequence; Binding Sites; CCR5 Receptor Antagonists; Cell Line; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Viral; Gene Library; HeLa Cells; HIV; HIV Envelope Protein gp120; HIV-1; Humans; Inhibitory Concentration 50; Models, Genetic; Molecular Sequence Data; Mutation; Plasmids; Polymorphism, Genetic; Protein Binding; Protein Structure, Tertiary; Quaternary Ammonium Compounds; Receptors, CCR5; Recombinant Proteins; Retroviridae; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Time Factors; Transfection | 2005 |